Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Shanghai China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 120KGS

    Contract Manufacturing: CRO,CMO

  • Sample Provided: yes

    Payment Terms: T/T

    Liraglutide API (CAS No. 204656-20-2) is a glucagon-like peptide-1 (GLP-1) analog modified with a C-16 fatty acid side chain to prolong half-life. It comprises 31 amino acids and is produced via recombinant DNA technology using Saccharomyces cerevisiae (baker’s yeast).
    Key Features:
    • High Purity: Complies with pharmacopeial standards (CP/EP), ensuring minimal impurities.
    • Bioactivity: Acts as a GLP-1 receptor agonist, enhancing glucose-dependent insulin secretion, suppressing glucagon, and delaying gastric emptying.
    • Applications: Treats type 2 diabetes mellitus, obesity, and reduces cardiovascular risk in high-risk patients.

    • Quality Assurance: Manufactured under cGMP; rigorously tested for identity, potency, sterility, endotoxins, and residual solvents.
    Storage: Stable at 2–8°C; protect from light and freezing.

Send your message to this supplier
  • From:
  • To:
    Yifan Pharmaceutical Co., Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service